Regulatory Issues

Featured Article

Drawing the Line Between Personal Beliefs and Patient Rights

Drawing the Line Between Personal Beliefs and Patient Rights

There's only one way to resolve the dissonance between personal beliefs and professional obligations: remembering that physicians take an oath pledging fealty to patients' health, not their own belief systems.

Latest

Scale of Online Marketplace for Marijuana Increasing

Scale of Online Marketplace for Marijuana Increasing

Researchers examined the scale and growth trajectory of the online marketplace for marijuana by analyzing aggregate internet searches and the links searchers typically found.

ACP: Position Paper Shares Top Principles of Volunteer Medical Experiences

ACP: Position Paper Shares Top Principles of Volunteer Medical Experiences

The position paper focuses on the 4 accepted principles of healthcare: beneficence, nonmaleficence, justice, and respect for autonomy.

Individual Consent for Health Research: Ethical Obligations vs Public Good

Individual Consent for Health Research: Ethical Obligations vs Public Good

A recent paper examines the circumstances in which public good outweighs the requirement that researchers receive individual consent to use a person's data.

Kratom-Containing Dietary Supplements Recalled

Kratom-Containing Dietary Supplements Recalled

The FDA said it wants all companies making kratom products to take them off the market, and urged all consumers who have kratom-containing products to stop using them and throw them away.

ACA Coverage Expansion Places Spending Burden on Low- to Middle-Income Households

ACA Coverage Expansion Places Spending Burden on Low- to Middle-Income Households

Although the Affordable Care Act's coverage expansions have reduced out-of-pocket spending for low- and middle-income individuals, these patients continue to experience a high burden of premium and out-of-pocket spending.

Evaluating the Consequences of the Federal Right-to-Try Legislation

Evaluating the Consequences of the Federal Right-to-Try Legislation

Federal "right-to-try" legislation will restrict the FDA's oversight of access to investigational drugs for patients with life-threatening illnesses and diminish the FDA's public health mission

Seven Potential Harmful Consequences of the CDC's Banned Words List

Seven Potential Harmful Consequences of the CDC's Banned Words List

Experts advise that should the CDC be banned from using certain words, it could give rise to at least 7 harmful consequences.

Congress Urged to Reverse CMS Policy That Could Affect Specialists, Patients

Congress Urged to Reverse CMS Policy That Could Affect Specialists, Patients

Many healthcare organizations are calling on Congress to reverse the new Centers for Medicare & Medicaid Services policy that has the potential to jeopardize patient access to Part B drug therapies.

FDA Accepts New Drug Application for Postoperative Ocular Pain, Inflammation

FDA Accepts New Drug Application for Postoperative Ocular Pain, Inflammation

The FDA has accepted a New Drug Application for an investigational topical twice-a-day product for the treatment of inflammation and pain in patients who have undergone ocular surgery.

Trump Administration Hands CDC a List of "Forbidden Words"

Trump Administration Hands CDC a List of "Forbidden Words"

Policy analysts at the Centers for Disease Control and Prevention have been informed to stop using certain terms in documents to be used in next year's budget.